American Journal of Obstetrics & Gynecology
Volume 197, Issue 3, Supplement , Pages S113-S122 , September 2007

Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments

  • Athena P. Kourtis, MD, PhD, MPH

      Affiliations

    • Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA
    • Corresponding Author InformationReprints: Athena P. Kourtis, MD, PhD, MPH, MS-K34, 4770 Buford Highway, Atlanta GA 30341
    • ,
  • Denise J. Jamieson, MD, MPH

      Affiliations

    • Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA
    • ,
  • Isabelle de Vincenzi, MD, PhD

      Affiliations

    • Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
    • ,
  • Allan Taylor, MD, MPH

      Affiliations

    • Division of HIV/AIDS Prevention, Surveillance, and Epidemiology, Atlanta, GA
    • ,
  • Michael C. Thigpen, MD

      Affiliations

    • Division of HIV/AIDS Prevention, Surveillance, and Epidemiology, Atlanta, GA
    • ,
  • Halima Dao, MD, MSc

      Affiliations

    • Global AIDS Program, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (proposed), Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Timothy Farley, PhD

      Affiliations

    • Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
    • ,
  • Mary Glenn Fowler, MD, MPH

      Affiliations

    • Johns Hopkins University–Makaere University Research Collaboration, Kampala, Uganda.

Received 15 December 2006 ,Revised 12 February 2007 ,Accepted 1 March 2007.

References 

  1. UNAIDS. 2004 Report on the global AIDS epidemic (4th Global Report). In: Joint United Nations Programme on HIV/AIDS (UNAIDS). 2004;p. 1–212Accessed April 26, 2007. Available at: www.unaids.org.
  2. Miotti PG, Taha TE, Kumwenda N, et al. HIV transmission through breastfeeding—a study in Malawi. JAMA. 1999;282:744–749
  3. Fawzi W, Msamanga G, Spiegelman D, Hunter DJ. Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2002;31:331–338
  4. Fowler MG, Newell ML. Breastfeeding and HIV-1 transmission in resource-limited settings. J AIDS. 2002;30:230–239
  5. DeCock K, Fowler MG, Mercier L, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283:1175–1182
  6. Embree JE, Njenga S, Datta P, et al. Risk factors for postnatal mother to child transmission of HIV-1. AIDS. 2000;14:2535–2541
  7. Lewis P, Nduati R, Kreiss JK, et al. Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis. 1998;1771:34–39
  8. Rousseau CM, Nduati RW, Richardson BA, et al. Longitudinal analysis of HIV-1 RNA in breast milk and its relationship to infant infection and maternal disease. J Infect Dis. 2003;187:741–747
  9. The Breastfeeding and HIV International Transmission Study Group. Late postnatal transmission of HIV-1 in breastfed children: an individual patient data meta-analysis. J Infect Dis. 2004;189:2154–2166
  10. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000;283:1167–1174
  11. Moodley D, Moodley J, Coovadia H, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 2003;187:725–735
  12. Thior I, Lockman S, Smeaton L, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother to child HIV transmission in Botswana: a randomized trial: the Mashi study. JAMA. 2006;296:794–805
  13. John GC, Nduati RW, Mbori-Ngacha DA, et al. Correlates of mother to child HIV-1 transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis. 2001;183:206–212
  14. Richardson BA, John-Stewart GC, Hughes J, et al. Breast milk infectivity in HIV-1 infected mothers. J Infect Dis. 2003;1887:736–740
  15. Semba RD, Kumwenda N, Taha TE, et al. Mastitis and immunological factors in breast milk of lactating women in Malawi. Clin Diagn Lab Immunol. 1999;6:671–674
  16. Fultz PN. HIV-1 superinfections: omens for vaccine efficacy?. AIDS. 2004;18:115–119
  17. Kumwenda N, Miotti P, Taha T, et al. Antenatal vitamin A supplementation increases birth weight and decreases anemia among infants born to human immunodeficiency virus-infected women in Malawi. Clin Infect Dis. 2002;35:618–624
  18. Coutsoudis A, Pillay K, Spooner E, et al. Influence of infant feeding patterns on early mother to child transmission of HIV-1 in Durban, South Africa. Lancet. 1999;354:471–476
  19. Rollins N, Meda N, Becquet R, et al. Preventing postnatal transmission of HIV-1 through breastfeeding: modifying infant feeding practices. J Acquir Immune Defic Syndr. 2004;35:188–195
  20. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of HIV-1 transmission through breastfeeding. Lancet. 1992;340:585–588
  21. Semba R, Kumwenda N, Taha T, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 1999;180:93–98
  22. Nduati R, John G, Richardson B, et al. Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis. 1995;172:1461–1468
  23. Toniolo A, Serra C, Conaldi PG, Basolo F, Falcone V, Dolei A. Productive HIV-1 infection of normal human mammary epithelial cells. AIDS. 1995;9:859–866
  24. Becquart P, Chomont N, Roques P, et al. Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology. 2002;300:109–117
  25. Henderson GJ, Hoffman NG, Ping LH, et al. HIV-1 populations in blood and breast milk are similar. Virology. 2004;330:295–303
  26. Willumsen J, Filteau SM, Coutsoudis A, et al. Breast milk RNA viral load in HIV-1 infected South African women: effects of subclinical mastitis and infant feeding. AIDS. 2003;17:407–414
  27. Hartmann SU, Berlin CM, Howett MK. Alternative modified infant-feeding practices to prevent postnatal transmission of HIV-1 through breast milk: past, present and future. J Hum Lact. 2006;22:75–88
  28. Gannt S, Katzenstein D, Shetty A, et al. Associations between breast milk cellularity, microbial pathogens, and viral shedding in HIV-1-infected women. 2006;Presented at the Abstracts of the 13th Annual Conference on Retroviruses and Opportunistic Infections, Denver, CO, February 5-8, Abstract 728.
  29. Koulinska IN, Villamor E, Chaplin B, et al. Transmission of cell-free and cell-associated HIV-1 through breast feeding. Virus Res. 2006;120:191–198
  30. Shapiro RL, Ndungu T, Lockman S, et al. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J Infect Dis. 2005;192:713–719
  31. Giuliano M, Guidotti G, Andreotti M, et al. Triple therapy during pregnancy and after delivery significantly reduces breast milk viral load: a substudy of the DREAM program. 2006;Presented at the Abstracts of the 13th Annual Conference on Retroviruses and Opportunistic Infections, Denver, CO, February 5-8, Abstract 727.
  32. Chung MH, Kiarie JN, Richardson BA, et al. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine. AIDS. 2005;19:1415–1422
  33. Shapiro RL, Hollant DT, Capparelli E, et al. Antiretroviral concentrations in breast feeding infants of women in Botswana receiving antiretroviral treatment. J Infect Dis. 2005;192:720–727
  34. Kuhn L, Trabattoni D, Kankasa C, et al. A-defensins in the prevention of HIV transmission among breastfed infants. J Acquir Immune Defic Syndr. 2005;39:138–142
  35. Mitchie CA, Tanctscher E, Schall T, et al. Physiological secretion of chemokines in human breast milk. Eur Cytokine Netw. 1998;9:603–608
  36. Kourtis AP, Butera S, Ibegbu C, Belec L, Duerr A. Breast milk and HIV-1: vector of transmission or vehicle of protection?. Lancet Infect Dis. 2003;3:786–793
  37. Farquhar C, VanCott T, Mbori-Ngacha DA, et al. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of HIV-1 through breast milk. J Infect Dis. 2002;186:1173–1176
  38. Van De Perre P, Simonon A, Hitimara DG, et al. Infective and anti-infective properties of breast milk from HIV-infected women. Lancet. 1993;341:914–918
  39. Becquart P, Hocini H, Garin B, et al. Compartmentalization of the IgG immune response to HIV-1 in breast milk. AIDS. 1999;13:1323–1331
  40. Bertotto A, Gerli R, Fabietti G, et al. Human breast milk T cells display the phenotype and functional characteristics of memory T cells. Eur J Immunol. 1990;20:1877–1880
  41. Sabbaj S, Edwards BH, Ghosh MK, et al. Human immunodeficiency virus-specific CD8+ T cells in human breast milk. J Virol. 2002;76:7365–7373
  42. Kourtis AP, Ibegbu CC, Theiler R, et al. Breast milk CD4+ T cells express high levels of CCR5 and CxCR4 and are preserved in HIV infection. J Infect Dis. 2007;195:965–972
  43. Ichikawa M, Masahiko S, Takahashi M, et al. Breast milk macrophages spontaneously produce granulocyte-macrophage colony stimulating factor and differentiate into dendritic cells in the presence of exogenous interleukin-4 alone. Immunol. 2003;108:189–195
  44. Satomi M, Shimizu M, Shinya E, et al. Transmission of macrophage-tropic HIV-1 by breast milk macrophages via DC-SIGN. J Infect Dis. 2005;191:174–181
  45. Iliff PJ, Piwoz EG, Tavengwa NV, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS. 2005;19:699–708
  46. Smith MM, Kuhn L. Exclusive breast feeding: does it have the potential to reduce breastfeeding transmission of HIV-1?. Nutr Rev. 2000;58:333–340
  47. Peaker M. Ion and water transport in the mammary gland. In:  Larson BL editors. Lactation: a comprehensive treatise. Vol 4:New York (NY: Academic Press; 1978;p. 437–462
  48. Neville MC, Allen JC, Archer P, et al. Studies in human lactation: milk volume and nutrient composition during weaning and lactogenesis. Am J Clin Nutr. 1991;54:81–92
  49. World Health Organization. HIV and infant feeding. In: Guidelines for decision makers. Department of Child and Adolescent Health and Development, Department of HIV/AIDS, and Department for Nutrition and Health for Development, World Health Organization. 2003;p. 1–86Available at: www.who.int. Accessed May 30, 2006.
  50. Thomas T, Masaba R, Van Eijk A, Ndila C, Fowler MG, Slutsker L. Comparison of rates of diarrhea among infants in the Kisumu Breastfeeding Study, and the Vertical Transmission Study, Kisumu, Kenya. 2005;Presented at the 14th International Conference on HIV/AIDS and Sexually Transmitted Infections in Africa (ICASA), December 4-9, Abuja, Nigeria. Abstract.
  51. Thomas T, Taren D, Van Eijk A, Mofenson L, Fowler MG. Is exclusive breastfeeding and abrupt weaning at 6 months resulting in impaired weight gain among infants born to HIV positive mothers receiving HAART for 6 months?. 2005;Presented at the 18th International Conference of Nutrition, August 2-5, Durban, South Africa. Abstract.
  52. Lockman S, Smeaton L, Shapiro R, et al. Mashi Study Team Morbidity and mortality among infants born to HIV-infected mothers and randomized to breastfeeding versus formula-feeding in Botswana (Mashi study). 2006;Program and abstracts of the XVI International AIDS Conference, August 13-18, Toronto. Abstract TUPE0357.
  53. Nussenblatt V, Lema V, Kumwenda N, et al. Epidemiology and microbiology of subclinical mastitis among HIV-infected women in Malawi. Int J STD AIDS. 2005;16:227–232
  54. Gomo E, Filteau S, Tomkins A, et al. Subclinical mastitis among HIV-infected and uninfected Zimbabwean women participating in a multimicronutrient supplementation trial. Trans R Soc Trop Med Hyg. 2003;97:12–16
  55. Nussenblatt V, Kumwenda N, Lema V, et al. Effect of antibiotic treatment of subclinical mastitis on human immunodeficiency virus type 1 RNA in human milk. J Trop Pediatr. 2006;52:311–315
  56. Fawzi W, Hunter D. Vitamins in HIV disease progression and vertical transmission. Epidemiology. 1998;9:457–466
  57. Semba R, Miotti P, Chiphangwi J, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet. 1994;343:1593–1597
  58. Semba R. Overview of the potential role of vitamin A in mother-to-child transmission of HIV-1. Acta Paediatr Suppl. 1997;421:107–112
  59. Greenberg B, Semba R, Vink P, et al. Vitamin A deficiency and maternal-infant transmissions of HIV in two metropolitan areas in the United States. AIDS. 1997;11:325–332
  60. Coutsoudis A, Pillay K, Spooner E, et al. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa (South African Vitamin A Study Group). AIDS. 1999;13:1517–1524
  61. Fawzi W, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS. 2002;16:1935–1944
  62. Humphrey J, Iliff P, Marinda ET, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis. 2006;193:860–871
  63. Hartmann SU, Wigdahl B, Neely EB, et al. Biochemical analysis of human milk treated with sodium dodecyl sulphate, an alkyl sulphate microbicide that inactivates HIV-1. J Hum Lact. 2006;22:61–74
  64. Eglin RP, Wilkinson AR. HIV infection and pasteurization of breast milk (letter). Lancet. 1987;1:1093
  65. Orloff SL, Wallingford JC, McDougal JS. Inactivation of HIV-1 in human milk: effects of intrinsic factors in human milk and of pasteurization. J Hum Lact. 1993;9:13–17
  66. Jeffery B, Mercer K. Pretoria pasteurisation: a potential method for the reduction of postnatal mother to child transmission of the human immunodeficiency virus. J Trop Pediatr. 2000;46:219–223
  67. Jeffery B, Soma-Pillay P, Makin J, et al. The effect of Pretoria pasteurization on bacterial contamination of hand-expressed human breast milk. J Trop Pediatr. 2003;49:240–244
  68. Jeffery B, Webber L, Mokhondo K, et al. Determination of the effectiveness of inactivation of human immunodeficiency virus by Pretoria pasteurization. J Trop Pediatr. 2001;47:345–349
  69. Yeo E, Bequet L, Ekouevi D, et al. Attitudes towards exclusive breastfeeding and other infant feeding options—a study from Abidjan, Côte d’Ivoire. J Trop Pediatr. 2005;51:223–226
  70. Savarino A, Gennero L, Chen HC, et al. Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity. AIDS. 2001;15:2221–2229
  71. Sperber K, Chiang G, Chen H, et al. Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with HIV-1. Clin Ther. 1997;19:913–923
  72. Boelaert JR, Yaro S, Augustijns P, et al. Chloroquine accumulates in breast-milk cells: potential impact in the prophylaxis of postnatal mother to child transmission of HIV-1. AIDS. 2001;15:2205–2207
  73. Luchters SM, Veldhuijzen NJ, Nsanzabera D, et al. A phase I/II randomized, placebo controlled study to evaluate chloroquine administration to reduce HIV-1 RNA in breast milk in an HIV-1 infected breastfeeding population: the CHARGE study. 2004;Presented at the Abstracts of the International Conference of AIDS, July 11-16, Abstract TuPeB4499.
  74. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomized controlled trial. Lancet. 1999;353:773–780
  75. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d’Ivoire: a randomized trial. Lancet. 1999;353:781–785
  76. Dabis F, Msellati P, Meda N, et al. Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d’Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet. 1999;353:786–792
  77. The Petra Study Team. Efficacy of the three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa and Uganda (Petra Study): a randomized, double-blind, placebo-controlled trial. Lancet. 2002;359:1178–1186
  78. Guay L, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet. 1999;354:795–802
  79. Jackson B, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomized trial. Lancet. 2003;362:859–867
  80. Lallemant M, Jourdain G, Le Coeur S, et al. A randomized, double-blind trial assessing the efficacy of single-dose perinatal nevirapine added to a standard zidovudine regimen for the prevention of mother-to-child transmission of HIV-1 in Thailand. 2004;Presented at the 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, California, February (Abstract 40LB).
  81. Dabis F, Ekouevi DK, Rouet F, et al. Effectiveness of a short course of zidovudine + lamivudine and peripartum nevirapine to prevent HIV-1 mother-to-child transmission: the ANRS DITRAME Plus trial, Abidjan, Côte d’Ivoire. Antiviral Therapy. 2003;8(Suppl 1):S236–S237
  82. Ruprecht RM, Ferrantelli F, Kitabwalla M, Xu W, McClure HM. Antibody protection: passive immunization of neonates against oral AIDS virus challenge. Vaccine. 2003;21:3370–3373
  83. Ferrantelli F, Rasmussen RA, Buckley KA, et al. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies. J Infect Dis. 2004;189:2167–2173
  84. Coovadia HM. Prevention and treatment of perinatal HIV-1 infection in the developing world. Curr Opin Infect Dis. 2000;13:247–251
  85. Thea DM, Vwalika C, Kasonde P, et al. Issues in the design of a clinical trial with a behavioral intervention—the Zambia exclusive breastfeeding study. Control Clin Trials. 2004;25:353–365

 The views expressed herein are those of the authors and do not necessarily reflect those of the Centers for Disease Control and Prevention or the World Health Organization.

PII: S0002-9378(07)00293-1

doi: 10.1016/j.ajog.2007.03.003

American Journal of Obstetrics & Gynecology
Volume 197, Issue 3, Supplement , Pages S113-S122 , September 2007

Article Tools